Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 20   

Articles published

ENZN 0.988 +0.090 (9.99%)
price chart
Enzon Pharmaceuticals Just Went from Good to Great (ENZN)
With just a quick glance at the company's recent news (or lack thereof), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) doesn't look like anything all that special... or even trade-worthy. It only takes a brief look at the chart of ENZN, however, to conclude ...
Stocks in the Spotlight - Tranzbyte Corp (ERBB), Emerald Oil, Inc. (EOX ...  Techsonian (press release)
Related articles »  
Enzon Pharmaceuticals Surges Post-Klarman Sale
Today's midday gainers are Enzon Pharmaceuticals Inc (NASDAQ:ENZN), Gilead Sciences, Inc. (NASDAQ:GILD) and Sirius XM Holdings Inc. (NASDAQ:SIRI).
Biotech Volatile Stocks: BIND Therapeutics (NASDAQ:BIND), Oncomed ...
Biotech Volatile Stocks: BIND Therapeutics (NASDAQ:BIND), Oncomed Pharmaceuticals Inc (NASDAQ:OMED), Advaxis (NASDAQ:ADXS), Enzon Pharmaceuticals Inc (NASDAQ:ENZN). BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine ...
Related articles »  
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) Stock Decreases
Dallas, Texas 03/25/2014 (FINANCIALSTRENDS) - Last week, a United States District Court denied Santaris Pharma's 2nd bid to have the patent- infringement lawsuit that was filed against it by the Isis Pharmaceuticals to be thrown out. The court ruled ...
Stocks in the Spotlight - Enzon Pharmaceuticals Inc(ENZN), MeetMe Inc (MEET ...  Techsonian (press release)
Related articles »  
Notable Movers - Discovery Laboratories, Inc. (NASDAQ:DSCO), Enzon ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) is engaged in licensing drug products. Its marketed drug products comprise PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for ...
Related articles »  
Healthcare Most Volatile: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), OXiGENE ...
The most recent short interest data has been released by the NASDAQ for the 02/14/2014 settlement date, which shows a 372,586 share increase in total short interest for Enzon Pharmaceuticals Inc (NASDAQ:ENZN) to 1,161,223, an increase of 47.24% ...
Biotech Gainers: InterMune (NASDAQ:ITMN), Aastrom Biosciences (NASDAQ:
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) weekly performance is 21.15%. On last trading day company shares ended up $1.26. Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) distance from 50-day simple moving average (SMA50) is 24.98%. Analysts ...
Related articles »  
Klarman Closes Position On Enzon Ahead Of Likely Delisting
After shaving his position several times, Baupost Group LLC manager Seth Klarman has finally closed his position on Enzon Pharmaceuticals Inc (NASDAQ:ENZN) ahead of its likely de-listing from the NASDAQ. The company is pretty small compared to the ...
Healthcare Gainers: InterMune Inc (NASDAQ:ITMN), Aastrom Biosciences Inc ...
Healthcare Gainers: InterMune Inc (NASDAQ:ITMN), Aastrom Biosciences Inc (NASDAQ:ASTM), Enzon Pharmaceuticals Inc (NASDAQ:ENZN), Genetic Technologies Limited (ADR) (NASDAQ:GENE).
Bullish Stocks At NASDAQ: InterMune (ITMN), NII Holdings (NIHD), FuelCell ...  eFinance Hub
Related articles »  
Why NII Holdings Inc (NASDAQ:NIHD), 6 others jumped? � Unwired Planet ...
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) jumped 16.67% ahead of its expected Q4 results on Mar 24, 2014. Ann Inc (NYSE:ANN) rallied 12.95% to more than 5-year high after Private-equity firm Golden Gate Capital announced a major stake in the ...
Related articles »